Trial Profile
A Comparison of Body Weight Changing and Side Effects Between Treatment With 30 Mcg Ethinylestradiol/2 mg Chlormadinone Acetate (Belara) and 30 Mcg Ethinylestradiol/3 mg Drospirenone (Yasmin): A Randomized Control Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2020
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; Ethinylestradiol/chlormadinone (Primary)
- Indications Pregnancy
- Focus Adverse reactions
- 01 Feb 2020 Status changed from recruiting to completed, according to results published in the European Journal of Contraception and Reproductive Health Care
- 07 Jun 2012 New trial record